Important Information

THIS WEBSITE IS INTENDED FOR INSTITUTIONAL INVESTORS who are U.S. residents ONLY; not intended for access or distribution to retail investors.

 

In order to access the Capital Group U.S. Institutional website (the “Site”), please read the following information and affirm by clicking the accept button that you have read and understand the information provided.

 

You must attest that you meet the qualifications of an institutional investor as described herein and accept these Terms and Conditions in order to access the Site. Some content may require additional registration for access.

 

The Site is solely intended for U.S. residents who are institutional investors or are acting on behalf of an institutional investor who has agreed to these Terms and Conditions. Institutional investors include, but are not limited to any person acting on behalf of/any pension fund, financial intermediary, consultant, endowment and foundation, bank, savings and loan association, insurance company, investment company registered under the Investment Company Act of 1940, investment adviser registered with the U.S. Securities and Exchange Commission or under applicable state law, government entity, entity with total assets of at least $50 million, employee benefit or qualified retirement plan with at least 100 participants, defined contribution/benefit plan, and qualified client or purchaser as defined by the U.S. Securities and Exchange Commission. By agreeing to these Terms and Conditions you are affirming your understanding that the Site is not intended for retail investors, individual plan participants or others who may not possess the financial sophistication to independently understand the content nor should it be redistributed to such persons.

 

You understand that the Site does not constitute advice of any nature, including fiduciary investment advice by Capital Group or its associates.

 

The reference to “Capital Group” used herein includes The Capital Group Companies, Inc., and its affiliates.

Investment Fund

BACK TO FUND'S DETAIL PAGE

All Holdings

390 Total Holdings:
As of 6/30/26
All Holdings: 1 - 15 of 390
Security Name Asset Type Shares or
Principal Amount 		Market Value Percent of
Net Assets descending arrow
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 136,543,202 $10,484,967,511.00 7.45%
SK hynix, Inc. Equity 4,086,149 $7,209,255,478.00 5.13%
Capital Group Central Cash Fund Short Term 49,688,975 $4,968,400,593.00 3.53%
ASML Holding NV Equity 1,711,576 $3,394,469,257.00 2.41%
SoftBank Group Corp. Equity 69,688,688 $2,614,554,311.00 1.86%
UniCredit SpA Equity 22,137,984 $1,980,624,958.00 1.41%
AstraZeneca PLC Equity 9,864,640 $1,845,461,571.00 1.31%
Cenovus Energy, Inc. Equity 72,716,972 $1,804,273,044.00 1.28%
Airbus SE, non-registered shares Equity 7,972,691 $1,774,537,948.00 1.26%
Samsung Electronics Co., Ltd. Equity 8,025,505 $1,754,512,189.00 1.25%
Novo Nordisk AS, Class B Equity 36,203,561 $1,736,858,118.00 1.23%
First Quantum Minerals, Ltd. Equity 53,134,924 $1,451,399,228.00 1.03%
Tokyo Electron, Ltd. Equity 2,888,448 $1,396,834,787.00 0.99%
Rolls-Royce Holdings PLC Equity 68,207,535 $1,309,595,785.00 0.93%
Safran SA Equity 3,180,054 $1,257,273,292.00 0.89%
All Holdings: 1 - 15 of 390